ArticleInternational journal of cancer2020

In vitro elimination of epidermal growth factor receptor-overexpressing cancer cells by CD32A-chimeric receptor T cells in combination with cetuximab or panitumumab.

Sara Caratelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.